Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
PubMed PMID: 23828641
InChi: InChI=1S/C22H16F4N6O2/c23-16-6-5-12(10-17-13-3-1-2-4-14(13)19(33)29-28-17)9-15(16)20(34)31-7-8-32-18(11-31)27-21(30-32)22(24
PMID: 31927622
Molecular Weight: 347
CN(C)C(=O)OC1C=CC=[N+](C)C=1
ENMD-2076 tartrate - CAS# 1291074-87-7 lol metabolite 4-Hydroxyphenyl Carvedilol PubMed PMID: 23828641ENMD 2076 is an orally active, Aurora A angiogenic kinase inhibitor with a unique kinase selectivity profile and multiple mechanisms of action. ENMD 2076 has been shown to inhibit a distinct profile of angiogenic tyrosine kinase targets in addition to the Aurora A kinase. Aurora kinases are key regulators of mitosis (cell division), and are often over expressed in human cancers. ENMD 2076 also targets the VEGFR, Flt 3 and FGFR3 kinases which have been
US$ 41.00
US$ 46.00
US$ 39.95
US$ 39.00
US$ 49.00
US$ 39.95
US$ 41.00
US$ 86.00
US$ 44.00
US$ 41.00
US$ 31.00
US$ 54.95
US$ 46.00
US$ 46.00
US$ 39.00